New enzyme drug tested in healthy volunteers
NCT ID NCT07484893
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial will test a new drug called recombinant human hyaluronidase in 24 healthy Chinese men. The drug is an enzyme that may help other medications spread more easily under the skin. The main goal is to check safety, how the body processes the drug, and whether it causes an immune response.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- recombinant human hyaluronidase
- What this could lead to
- If successful, this could help develop a drug that helps other medications spread more easily under the skin.
- What could go wrong
- This is a very early, small trial in healthy volunteers, so it won't test any disease treatment. The drug may cause allergic reactions or injection site issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT MALE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Second Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple vest make breathing easier?
- Chilly workouts may alter what you eat, small study suggests
- New Parkinson's drug MF1 enters first human safety trial
- AI-Powered training cuts hamstring injury risk in pro footballers
- Beta-Alanine boost for cyclists? new study reveals mixed results
- New Egg-Maturing technique could help women with low IVF success